Replies to post #661323 on NorthWest Biotherapeutics Inc (NWBO)

[reg2015]

skitahoe. Thank you for your AM reply to Doc Logic. My questions to you, if you would be so kind, is 1. what is EDEN?
2. If we submitted to Great Britain, why could not use the same information and submit it to Germany, Canada and the FDA?

Thank you and Peace Reg2015

[Doc logic]

skitahoe,

I agree, it’s not mandatory and I use the term partnership loosely to include any development agreement that brings in revenue over and above NWBO costs fir such a deal. For example, a combo trial where the combo partner pays for L at a price above cost so that NWBO shareholders are making more percentage wise and in absolute dollars than Advent owners. Any deal that does not adhere to this model would be a potential conflict of interest by Linda/Advent against the interests of Linda/NWBO shareholders because that would no longer be just an independent development cost. Best wishes.